Global Peptide Therapeutics Market Analysis 2013-2018 and Forecast 2019-2024

Table of Contents

1 Industry Overview

• 1.1 Peptide Therapeutics Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Peptide Therapeutics
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Peptide Therapeutics Market by Type

• 3.1 By Type
  • 3.1.1 Injection
  • 3.1.2 Oral
  • 3.1.3 Others
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Peptide Therapeutics Sanofi (Company Profile, Sales Data etc.)

• 4.2 Teva (Company Profile, Sales Data etc.)
• 4.3 Novo Nordisk (Company Profile, Sales Data etc.)
• 4.4 Takeda (Company Profile, Sales Data etc.)
• 4.5 Eli Lilly (Company Profile, Sales Data etc.)
• 4.6 AstraZeneca (Company Profile, Sales Data etc.)
• 4.7 Novartis (Company Profile, Sales Data etc.)
• 4.8 Shire (Company Profile, Sales Data etc.)
• 4.9 AbbVie (Company Profile, Sales Data etc.)
• 4.10 Ipsen (Company Profile, Sales Data etc.)
• 4.11 Allergan (Company Profile, Sales Data etc.)
• 4.12 Ferring (Company Profile, Sales Data etc.)
• 4.13 Merck (Company Profile, Sales Data etc.)
• 4.14 The Medicines (Company Profile, Sales Data etc.)
• 4.15 Roche (Company Profile, Sales Data etc.)
• 4.16 J & J (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Cancer
  • 6.1.2 Demand in Metabolic Disorders
  • 6.1.3 Demand in Central Nervous System
  • 6.1.4 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Peptide Therapeutics

Table Application Segment of Peptide Therapeutics

Table Global Peptide Therapeutics Market 2013-2024, by Application, in USD Million

Table Major Company List of Injection

Table Major Company List of Oral

Table Major Company List of Others

Table Global Peptide Therapeutics Market 2013-2018, by Type, in USD Million

Table Global Peptide Therapeutics Market 2013-2018, by Type, in Volume

Table Global Peptide Therapeutics Market Forecast 2019-2024, by Type, in USD Million

Table Global Peptide Therapeutics Market Forecast 2019-2024, by Type, in Volume

Table Sanofi Overview List

Table Peptide Therapeutics Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Teva Overview List

Table Peptide Therapeutics Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novo Nordisk Overview List

Table Peptide Therapeutics Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Takeda Overview List

Table Peptide Therapeutics Business Operation of Takeda (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eli Lilly Overview List

Table Peptide Therapeutics Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AstraZeneca Overview List

Table Peptide Therapeutics Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table Peptide Therapeutics Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Shire Overview List

Table Peptide Therapeutics Business Operation of Shire (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AbbVie Overview List

Table Peptide Therapeutics Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Ipsen Overview List

Table Peptide Therapeutics Business Operation of Ipsen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Allergan Overview List

Table Peptide Therapeutics Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Ferring Overview List

Table Peptide Therapeutics Business Operation of Ferring (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck Overview List

Table Peptide Therapeutics Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table The Medicines Overview List

Table Peptide Therapeutics Business Operation of The Medicines (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Roche Overview List

Table Peptide Therapeutics Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table J & J Overview List

Table Peptide Therapeutics Business Operation of J & J (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Peptide Therapeutics Sales Revenue 2013-2018, by Company, in USD Million

Table Global Peptide Therapeutics Sales Revenue Share, by Company, in USD Million

Table Global Peptide Therapeutics Sales Volume 2013-2018, by Company, in Volume

Table Global Peptide Therapeutics Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Peptide Therapeutics Demand Forecast 2019-2024, by Application, in USD Million

Table Peptide Therapeutics Demand Forecast 2019-2024, by Application, in Volume

Table Peptide Therapeutics Production 2013-2018, by Region, in USD Million

Table Peptide Therapeutics Production 2013-2018, by Region, in Volume

Table Global Peptide Therapeutics Market 2013-2018, by Region, in USD Million

Table Global Peptide Therapeutics Market Share 2013-2018, by Region, in USD Million

Table Global Peptide Therapeutics Market 2013-2018, by Region, in Volume

Table Global Peptide Therapeutics Market Share 2013-2018, by Region, in Volume

Table North America Peptide Therapeutics Market Size 2013-2018, by Country, in USD Million

Table North America Peptide Therapeutics Market Size 2013-2018, by Country, in Volume

Table Europe Peptide Therapeutics Market Size 2013-2018, by Country, in USD Million

Table Europe Peptide Therapeutics Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Peptide Therapeutics Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Peptide Therapeutics Market Size 2013-2018, by Country, in Volume

Table South America Peptide Therapeutics Market Size 2013-2018, by Country, in USD Million

Table South America Peptide Therapeutics Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Peptide Therapeutics Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Peptide Therapeutics Market Size 2013-2018, by Country, in Volume

Table Peptide Therapeutics Market Forecast 2019-2024, by Region, in USD Million

Table Peptide Therapeutics Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Peptide Therapeutics Market Growth 2013-2018, by Type, in USD Million

Figure Global Peptide Therapeutics Market Growth 2013-2018, by Type, in Volume

Figure North America Peptide Therapeutics Market Concentration, in 2018

Figure Europe Peptide Therapeutics Market Market Concentration, in 2018

Figure Asia-Pacific Peptide Therapeutics MMarket Concentration, in 2018

Figure South America Peptide Therapeutics Market Concentration, in 2018

Figure Middle East & Africa Peptide Therapeutics Market Concentration, in 2018

Figure Peptide Therapeutics Demand in Cancer, 2013-2018, in USD Million

Figure Peptide Therapeutics Demand in Cancer, 2013-2018, in Volume

Figure Peptide Therapeutics Demand in Metabolic Disorders, 2013-2018, in USD Million

Figure Peptide Therapeutics Demand in Metabolic Disorders, 2013-2018, in Volume

Figure Peptide Therapeutics Demand in Central Nervous System, 2013-2018, in USD Million

Figure Peptide Therapeutics Demand in Central Nervous System, 2013-2018, in Volume

Figure Peptide Therapeutics Demand in Others, 2013-2018, in USD Million

Figure Peptide Therapeutics Demand in Others, 2013-2018, in Volume

Figure North America Peptide Therapeutics Market Size and Growth 2013-2018, in USD Million

Figure North America Peptide Therapeutics Market Size and Growth 2013-2018, in Volume

Figure Europe Peptide Therapeutics Market Size and Growth 2013-2018, in USD Million

Figure Europe Peptide Therapeutics Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Peptide Therapeutics Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Peptide Therapeutics Market Size and Growth 2013-2018, in Volume

Figure South America Peptide Therapeutics Market Size and Growth 2013-2018, in USD Million

Figure South America Peptide Therapeutics Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Peptide Therapeutics Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Peptide Therapeutics Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview